Compare PTCT & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | NNI |
|---|---|---|
| Founded | 1998 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.6B |
| IPO Year | 2006 | 2003 |
| Metric | PTCT | NNI |
|---|---|---|
| Price | $56.37 | $121.03 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $100.47 | N/A |
| AVG Volume (30 Days) | ★ 939.5K | 97.2K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ 264.48 | 134.86 |
| EPS | 0.34 | ★ 5.95 |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $1.00 |
| Revenue Next Year | $8.29 | $9.83 |
| P/E Ratio | $171.44 | ★ $20.61 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $58.15 | $116.62 |
| 52 Week High | $90.87 | $144.38 |
| Indicator | PTCT | NNI |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 41.33 |
| Support Level | N/A | N/A |
| Resistance Level | $69.74 | $129.94 |
| Average True Range (ATR) | 2.50 | 3.71 |
| MACD | -0.78 | -0.50 |
| Stochastic Oscillator | 1.01 | 1.14 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems, which focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Asset Generation and Management.